Practice Management

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Videos
Interactive
Polls Quizzes

FDA Alerts

FDA Alert
fda sign
FDA Alert
FDA Approves First Generic Fluticasone Propionate Inhalation Aerosol for Asthma Maintenance Therapy in Patients Aged 4 Years and Older
03/03/2026
Anthony Calabro, MA
On March 3, 2026, the FDA approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 mcg per actuation, for the maintenance treatment of asthma as prophylactic therapy in...
03/03/2026
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
Practice Management
Practice Management
FDA Roundup: Powdered Gloves, Opioid Warnings, Anthrax
03/22/2016
The FDA has proposed a ban on powdered medical gloves, approved new requirements for opioid warning labels, and approved a new treatment for inhalational anthrax.
03/22/2016
FDA
FDA
The FDA and Doctors: Why We Need to Pay Attention
03/23/2015
William H. Eaglstein, MD
I am often surprised that any doctors and medical students miss the mark on what FDA stands for.
03/23/2015